累积多余体重指数和MGUS进展到髓瘤
Lawrence Liu1,2, Nikhil Grandhi1,3, Mei Wang1,4
1Research Service, St Louis Veterans Affairs Medical Center, St Louis, Missouri.
JAMA network open
|February 7, 2025
概括
累积多余体重指数 (EBMI) 增加了未知意义的单克隆性胃病变 (MGUS) 进展为多发性骨髓瘤 (MM) 的风险. 在MGUS诊断后保持健康的体重可能有助于预防这种进展.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 肥胖是多发性骨髓瘤 (MM) 和其前体,意义不明的单克隆性骨髓瘤病 (MGUS) 的已知危险因素.
- 累积肥胖暴露对从MGUS发展为MM的风险的影响尚不清楚.
研究的目的:
- 调查累积多余体重指数 (EBMI) 与从MGUS发展为MM的风险之间的关联.
- 确定持续的肥胖是否会影响MGUS发展为MM的速度.
主要方法:
- 一项队列研究分析了1999年至2021年间诊断出MGUS的22429名美国退伍军人的数据.
- 累计EBMI的计算是使用BMI在诊断后的前三年超过25的曲线下的面积.
- 采用多变量细灰竞争风险模型来评估EBMI和MGUS进展到MM之间的关联.
主要成果:
- 在MGUS诊断时体重指数 (BMI) 为25或以上的患者与正常BMI患者相比,患MM的风险更高.
- 在诊断时BMI正常的患者中,每年累积EBMI每增加1个单位都与进展风险增加21%有关.
- 对于在诊断时已经超重或肥胖的患者 (BMI ≥25),累积EBMI没有显示出与进展风险增加的统计学上显著关联.
结论:
- 累积的多余体重指数与MGUS进展到多发性骨髓瘤的风险增加有关,特别是在诊断时BMI正常的个体中.
- 在MGUS诊断后保持健康的体重和稳定的BMI可能是预防风险人群发展为MM的关键策略.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Obesity
366
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
366
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


